Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 21, 2005 11:48 ET | Source: ProtoKinetix, Incorporated

ProtoKinetix' Synthetic Antifreeze Glycoprotein is Now Trademarked as AAGP

VANCOUVER, British Columbia, Sept. 21, 2005 (PRIMEZONE) -- After extensive testing by ProtoKinetix, Inc. (OTCBB:PKTX) on a wide range of cells and tissue, the Company has determined that their...
September 07, 2005 10:49 ET | Source: ProtoKinetix, Incorporated

Increased Concentrations of ProtoKinetix's Synthetic AFGP Dramatically Slows Aging Process on Skin Cells

VANCOUVER, British Columbia, Sept. 7, 2005 (PRIMEZONE) -- Results just received clearly confirm that in the presence of ProtoKinetix's (OTCBB:PKTX) synthetic antifreeze glycoprotein (AFGP), the aging...
August 25, 2005 11:27 ET | Source: ProtoKinetix, Incorporated

ProtoKinetix Receives Remarkable Results from Study Using Synthetic AFGP on Skin Cells

VANCOUVER, British Columbia, Aug. 25, 2005 (PRIMEZONE) -- Dr. John Todd, president and CEO of ProtoKinetix, Inc. (OTCBB:PKTX) announces today the results of the in-vitro effect of their synthetic...
August 23, 2005 07:00 ET | Source: ProtoKinetix, Incorporated

ProtoKinetix Commences Organ Preservation Trials

VANCOUVER, British Columbia, Aug. 23, 2005 (PRIMEZONE) -- Following PKTX's (OTCBB:PKTX) successful testing of AFGP on heart cells announced July 18, 2005, the Company has just completed their initial...
July 27, 2005 12:27 ET | Source: ProtoKinetix, Incorporated

ProtoKinetix Announces Commercialization Strategy for AFGP

VANCOUVER, British Columbia, July 27, 2005 (PRIMEZONE) -- ProtoKinetix, Inc. (OTCBB:PKTX) management has identified the first three product lines ready for commercial development. This family of...
July 18, 2005 10:48 ET | Source: ProtoKinetix, Incorporated

Higher Concentrations of ProtoKinetix's Synthetic AFGP Show Significant Increase in Heart Cell Survivability

VANCOUVER, British Columbia, July 18, 2005 (PRIMEZONE) -- ProtoKinetix, Inc. (OTCBB:PKTX) announces that tests repeated by ProteoCell Biotechnologies, using higher concentrations of AFGP, in both...
July 14, 2005 12:05 ET | Source: ProtoKinetix, Incorporated

Collaborative Agreement Reached with Premier Research Institution

VANCOUVER, British Columbia, July 14, 2005 (PRIMEZONE) -- ProtoKinetix, Inc. (OTCBB:PKTX) announces a major collaborative agreement with one of the world's most prestigious blood specialty...
July 12, 2005 12:41 ET | Source: ProtoKinetix, Incorporated

Survival of Sensitive Heart Cells After Freezing Shows Promise for Increased Organ Shelf Life

VANCOUVER, British Columbia, July 12, 2005 (PRIMEZONE) -- Dr. John Todd, President and CEO of ProtoKinetix, Inc. (OTCBB:PKTX), reports today on the Company's progress towards the commercialization of...
May 19, 2005 07:00 ET | Source: ProtoKinetix, Incorporated

Second Generation Synthetic AFGP Tests Stable and Safe

VANCOUVER, British Columbia, May 19, 2005 (PRIMEZONE) -- The University of Rouen in France reports that their laboratory has completed an enzymatic study on the dimeric compound of synthetic AFGP,...
May 12, 2005 07:00 ET | Source: ProtoKinetix, Incorporated

University of Rouen Laboratory Announces Completion Of Second Generation Synthetic AFGP

VANCOUVER, British Columbia, May 12, 2005 (PRIMEZONE) -- Dr. Geraldine Deliencourt, of the University of Rouen, has informed ProtoKinetix (OTCBB:PKTX) that their laboratory has completed the...